# NITROGLYCERIN
> **ANDA218756** · Abbreviated New Drug Application (Generic) · Sponsor: SOLARIS PHARMA CORP · Approved 2025-12-18
## Drug
- **FDA Application Number:** ANDA218756
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NITROGLYCERIN
- **Generic name:** NITROGLYCERIN
- **Active ingredients:** NITROGLYCERIN
- **Dosage form:** OINTMENT
- **Route:** INTRA-ANAL
- **Marketing status:** Prescription
- **Sponsor:** SOLARIS PHARMA CORP
- **Manufacturer:** Solaris Pharma Corporation
- **First approval:** 2025-12-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218756)
---
*AI Analytics · CC0 1.0*